Nasivin (Oxymetazoline Hydrochloride)

Oxymetazoline Hydrochloride, the active ingredient in Nasivin, is an alpha‑adrenergic agonist presented as a nasal spray for intranasal use. It relieves nasal congestion caused by the common cold, sinusitis and allergic rhinitis in adults and children when used as directed.

GNH USA supplies Nasivin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nasivin, an alpha‑adrenergic nasal decongestant, is used to alleviate congestion in several upper‑respiratory conditions.

- Common cold: reduces nasal blockage associated with viral upper‑respiratory infection. - Acute sinusitis: eases mucosal swelling to improve sinus drainage. - Allergic rhinitis: diminishes congestion triggered by allergen exposure.

Oxymetazoline nasal spray may cause a range of adverse reactions. Most are mild and transient.

Common Side Effects: - Nasal irritation or burning sensation - Dryness of the nasal mucosa - Sneezing - Headache - Altered taste or bitter taste - Rebound congestion with prolonged use

Serious or Rare Side Effects: - Elevated blood pressure or hypertension - Cardiac arrhythmia - Severe nasal ulceration or septal perforation - Allergic reaction (rash, itching, swelling) - Nasal bleeding (epistaxis)

Before using Nasivin, consider the following safety measures.

- Duration of use: limit to no more than three consecutive days to avoid rebound congestion. - Hypertension: avoid or use with caution in patients with uncontrolled high blood pressure. - Cardiovascular disease: consult a healthcare professional if you have heart disease. - Children: do not use in children under six years of age unless directed by a physician. - Pregnancy and lactation: use only if clearly needed and prescribed by a clinician. - Store at room temperature: keep in the original container, protect from moisture and direct heat.

Oxymetazoline may interact with other medications; review the following categories.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Other topical nasal decongestants: additive vasoconstriction may increase systemic effects. - Systemic sympathomimetics (e.g., pseudoephedrine): may cause excessive blood pressure elevation.

Moderate Interactions (Monitor Closely): - Antihypertensive agents (beta‑blockers, ACE inhibitors): possible reduction in blood pressure‑lowering effect. - Tricyclic antidepressants: may enhance vasoconstrictive response. - Alcohol: can increase dizziness or nasal irritation.